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Background: Most low and middle income countries (LMICs) are currently not on track to reach the health-related
Millennium Development Goals (MDGs). One way to accelerate progress would be through the large-scale
implementation of evidence-based health tools and interventions. This study aimed to: (a) explore the barriers that
have impeded such scale-up in LMICs, and (b) lay out an “implementation research agenda”—a series of key
research questions that need to be addressed in order to help overcome such barriers.
Methods: Interviews were conducted with fourteen key informants, all of whom are academic leaders in the field
of implementation science, who were purposively selected for their expertise in scaling up in LMICs. Interviews
were transcribed by hand and manually coded to look for emerging themes related to the two study aims. Barriers
to scaling up, and unanswered research questions, were organized into six categories, representing different
components of the scaling up process: attributes of the intervention; attributes of the implementers; scale-up
approach; attributes of the adopting community; socio-political, fiscal, and cultural context; and research context.
Results: Factors impeding the success of scale-up that emerged from the key informant interviews, and which are
areas for future investigation, include: complexity of the intervention and lack of technical consensus; limited
human resource, leadership, management, and health systems capacity; poor application of proven diffusion
techniques; lack of engagement of local implementers and of the adopting community; and inadequate integration
of research into scale-up efforts.
Conclusions: Key steps in expanding the evidence base on implementation in LMICs include studying how to:
simplify interventions; train “scale-up leaders” and health workers dedicated to scale-up; reach and engage
communities; match the best delivery strategy to the specific health problem and context; and raise the low profile
of implementation science.Background
Most developing countries are currently not on track to
reach the health-related Millennium Development Goals
(MDGs) [1,2]. A major reason for their slow progress is
the “know-do gap”—the gap between what is known and
what gets implemented in low and middle income coun-
tries (LMICs) [3].The burden of illness in developing
countries could be reduced substantially if this gap wasCorrespondence: yameyg@globalhealth.ucsf.edu
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reproduction in any medium, provided the ornarrowed, i.e., if evidence-based tools and services were
scaled up. Up to 70% of deaths of children under 5 years,
for example, could be prevented through the large-scale
implementation of evidence-based interventions [4,5].
In discussing how to improve the health of the world’s
poor, McCannon and colleagues argue that “many sound
(even powerful) solutions exist, such as new medicines
and innovations in health care delivery, but their adop-
tion is unreliable and slow” [6].
The interventions that would help LMICs reach the
health MDGs, referred to in this paper as “global health
interventions,” are well defined. For example, The Bellagiohis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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preventive and therapeutic interventions that could re-
duce child mortality in LMICs [4]. However, while there
is a wealth of evidence on the efficacy and effectiveness of
such tools, there has been much less attention paid to
how to deliver them to scale [7-10]. Whitworth and col-
leagues frame the issue bluntly: “we do not know how
best to scale up interventions effectively” [10].
Insecticide-treated bed nets are a case in point. Such
nets reduce childhood malaria episodes by 50% and
malaria deaths by 20% [11]. And yet increasing the pro-
portion of children in malaria-endemic countries who
consistently sleep under a net has remained a difficult
global health challenge, and there is still “considerable
debate about how best to deliver nets” [12]. Delivering
evidence-based health interventions to the very poorest
and most remote communities in LMICs has proven to
be a particularly stubborn problem [13,14].
This study aimed to identify some of the key barriers
to scaling up health interventions in LMICs through
interviews with experts in large-scale implementation,
many of whom have led successful national or global
health scale-up campaigns, and all of whom have re-
search expertise in implementation science. The study
also aimed to identify some of the key unanswered re-
search questions that would help to advance the field of
implementation science in LMICs. The term “scaling
up” is now widely used in global public health discus-
sions, although there is still no agreed definition. In this
paper, I use a working definition proposed by Mangham
and Hanson, in which scaling up is described as “the
ambition or process of expanding the coverage of health
interventions” [15].
Methods
I contacted 14 public health professionals, purposively
selected for their expertise in implementing evidence-
based interventions at scale. These professionals were
chosen based on a combination of (a) their current or
previous experience in leadership roles at institutions
that scale up health interventions in LMICs (even if the
institutions themselves are or were based in high-income
countries [HICs]), and (b) their academic leadership in
the field of implementation science. The key informants
(KIs) were found through my own personal network of
contacts in global health research and practice (I currently
lead a university-based global health policy initiative),
supplemented by the technique of snowballing [16].
All 14 KIs agreed to be interviewed (they are identified
as KIs 1–14 in the Results section of the paper). Thir-
teen have expertise in scaling-up health tools or services
in LMICs, and one focuses on such scale-up in HICs.
At the time that the interviews were conducted, three
were based in LMICs, 9 in HICs, and two divided theirtime between LMICs and HICs. Table 1 gives their basic
demographic information, outlining their current pos-
ition; their previous experience relevant to scale-up;
the type of intervention that they have been involved in
scaling up or have studied (e.g., simple or complex, clin-
ical or public health, and individual or bundled interven-
tions); and their research background. In order to protect
KIs’ anonymity, no identifying information is included in
Table 1 or in the Results section of this paper.
I conducted three interviews in person and eleven by
phone. Interviews lasted 30–60 minutes, based on a
semi-structured questionnaire. Questions were aimed at
eliciting interviewees’ personal knowledge, “real world”
experience, and knowledge of the implementation sci-
ence literature. For example, one of the questions was:
“Based on your own personal experience and expertise,
what are your own beliefs about why scale up fails?”
Additional file 1 shows the semi-structured interview
guide. Interviews were transcribed by hand and were
manually coded to look for emerging themes related to
my two research questions: What are the some of the
key barriers to scaling up health interventions in LMICs?
What are some of the key unanswered research ques-
tions that would help to improve the science of scale-up
in LMICs? Coding was conducted using a constant com-
parative method [17].
I organized the results (i.e., the emerging themes on
barriers and unanswered research questions) into six cat-
egories, representing different components of the scaling
up process: (1) attributes of the tool or service being
scaled up; (2) attributes of the implementers; (3) choice
of scale-up approach or delivery strategy; (4) attributes
of the “adopting” community; (5) the socio-political, fis-
cal, and cultural context; and (6) the research context
(Figure 1). These categories were adapted from two pre-
vious typologies of scaling up—Hanson and colleagues’
typology of constraints to scaling up [18], and Simmons
and Shiffman’s typology of components affecting scale-
up success [19].
Ethics approval
This study was approved by the research ethics committee
of the London School of Hygiene & Tropical Medicine.
KIs gave their written informed consent for anonymized
quotations to be included in this paper. Any information
that would identify the KIs was removed from the paper
prior to publication to protect KIs’ anonymity.
Results
Attributes of the tool or service being scaled up
Complexity and lack of consensus
An important theme emerging from the key informant
interviews was that overly complex interventions are
difficult to scale up in LMICs (KIs 1–3, 14), particularly





Current position Previous experience relevant
to scale-up
Type of intervention scaled up
or studied (in current or
past positions)
Papers indexed in PubMed:
No. of papers, and key topics
of research
KI 1 Academic global health
post in a HIC; university
leadership post
Leadership of a multilateral
health agency, headquartered
in Europe; has led large-scale
implementation in LMICs
Experience in scaling up both
simple interventions (e.g. a specific
drug treatment) and complex
interventions (e.g. complex public
health promotion)
Approx. 300 papers; communicable
and non-communicable disease
control
KI 2 Academic global health
post in a HIC; university
leadership post
Previous academic posts;
leadership positions in two
multilateral organizations,
one headquartered in Europe
and the other in the US; has led
large-scale implementation
in LMICs
Experience in scaling up both
simple and complex interventions
Approx. 100 papers; global health
financing, child health, public health,
and communicable and non-
communicable disease control
KI 3 Academic global health
post in a HIC; leads health
service scale-up projects
in LMICs
Has led multiple health systems
improvement projects in LMICs
Experience in scaling up complex,
health systems interventions
in LMICs
Approx. 75 papers; scaling up health
systems improvements in LMICs,
financing of global health
KI 4 Academic public health




Research on scaling up in LMICs,
with a focus on building research
capacity and on health systems
Research on scaling up simple and
complex interventions
Approx. 30 papers; implementation
science in LMICs, global health
research prioritization
KI 5 Academic health policy
post in a HIC; specializes
in health systems reform
Research on health systems
reform in both LMICs and HICs
Research on scaling up complex
health systems improvements
Approx. 75 papers; health systems
financing in HICs and LMICs,
measurement of health system
performance
KI 6 Academic global health
post in a HIC; university
leadership post
Senior positions in national public
health service in a HIC
Research on, and experience in,
scaling up complex interventions
to control risk factors for non-
communicable diseases




KI 7 Academic post in global
health in a HIC; university
leadership post
Academic leadership positions
at national agencies in a HIC
that focus on global health
problems
Research on scaling up infectious
disease control interventions
in LMICs
Approx. 200 papers; infectious
disease control, global health
initiatives, health systems
strengthening in LMICs
KI 8 Academic public health
post; principal of a medical
school in a LIC in Africa
Led national scale-up campaigns
addressing communicable diseases
Research on, and experience in,
scaling up simple and complex
interventions to control
communicable diseases
Approx. 150 papers; control of
communicable diseases in LMICs,
global health training, health
systems strengthening
KI 9 Academic public health
post at a school of
global health in a HIC
Research on large-scale
implementation, with a focus on
communicable diseases; previous
senior positions in regional public
health service
Research on scaling up simple
and complex interventions
to control communicable diseases
Approx. 120 papers; infectious
disease epidemiology and control,
public health research methods
KI 10 Women’s health researcher
in a MIC in Latin America
Academic research posts in LIC
universities; leadership of a
regional research and
implementation initiative
Research on, and experience in,
scaling up individual and bundled
clinical interventions
Approx. 120 papers; scaling up
women’s health interventions
in LMICs
KI 11 Implementation science
researcher in a HIC
Academic public health posts,
with a focus on implementation
of health interventions
in a HIC
Research on, and experience in,
scaling up simple and complex
clinical and public health
interventions
Approx. 50 papers; implementation
science, quality improvement
in health care
KI 12 Director of a scale-up
program in a LIC
Background in clinical medicine
and global public health, dividing
time between a LIC and a HIC
Experience in scaling up simple
and complex interventions
in an LIC
3 papers; scaling up health system
interventions in LICs
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Table 1 Basic demographic information about key informants (to protect KIs’ anonymity, identifying information has
been removed) (Continued)
KI 13 Professor of epidemiology,
with a focus on global
public health, based at
a university in a HIC
Clinical trials, and public health
research related to women’s and
children’s health
Research on scaling up simple
and complex clinical and public
health interventions
Approx. 150 papers; scaling up
women’s and children’s health
interventions, global public health
KI 14 Senior leadership position
at an NGO that manages
large-scale implementation
in LMICs
Past background in business
and technology; senior role in a
major global initiative to
rapidly scale up a communicable
disease intervention
Experience in scaling up simple
and complex interventions in HICs
and LMICs
4 papers; large scale health
improvement
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that intervention.
“For many [interventions], that simplicity of consensus
isn’t there. For example, water purification or clean
water interventions—How to scale up? What kind?
What quality? What quantity? Should we involve the
private sector? We don’t see progress because there’s no
consensus on these questions.” (KI 2)
Key informants argued that an important avenue
for future research is on simplifying interventions for
scale-up. One KI mentioned the DART (Development ofFigure 1 Framework for categorizing the study results.AntiRetroviral Therapy) trial, which showed that anti-
retroviral therapy (ART) can be delivered safely without
costly, complicated laboratory monitoring, as an example
of the type of research that can help improve scale-up:
“For example, the DART trial asked, ‘how do we
simplify ART regimes?’ The KISS principles—keep it
short and simple—are very important.” (KI 1)
Attributes of the implementers
Limited capacity
Insufficient capacity in LMICs—human resource, leadership
and management, and health systems capacity—emerged in
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based interventions at scale (KIs 2, 4–9). KIs mentioned
research on expanding the workforce and on engaging pri-
vate actors, such as non-governmental organizations
[NGOs] and drug store owners, in scale-up processes as
important topics for implementation research (KIs 6,12).
“Human resource deficiencies are a barrier—not just
numbers, but a sense of being able to do things. There’s
a brain drain. Good people leave, siphoned off by
NGOs. Human resource deficiency is a critical issue.”
(KI 6)
“On the major workforce questions—how do we have a
bigger one? Keep people in place? Use people better?—
few solutions are evidence-based, except for task
shifting.” (KI 12)
A related barrier identified in this study was weak
leadership, governance, or management capacity, espe-
cially at the local level (KIs 2, 5, 7). Key informants sug-
gested that an important research question for improving
scale-up is whether it is possible to identify and foster
public health leaders (KIs 5,8,12,13).
“Leadership is hugely important. Leadership is a major
issue. Lots of systems have tried reengineering with
poor results, often because local and national
leadership are missing.” (KI 5)
“Is leadership transferable or must you live with it or
without it? Leadership really does matter—but can
you make better leaders?” (KI 5)
KIs also identified weak health systems as one of the
main bottlenecks to scaling up proven interventions and
to reaching the MDGs (KIs 5, 12).
“There are operational constraints at the local level—
manpower, buildings, the local constraints can vary.
You need local adoption, but there are local obstacles.”
(KI 5)
A final research question that emerged from the inter-
views, related specifically to the implementers them-
selves, was the question of how best to incentivize
provider behavior towards implementing interventions
to scale (KIs 3,5,13).
“How do you build in systems and incentives to
successfully build in implementation and sustain it
down the road? That question is never going to leave.
There’s interesting research around how you keep it
going.” (KI 3)Choice of scale-up approach or delivery strategy
Failure to actively spread knowledge of an innovation
Key informants suggested that scale-up of a health
innovation may fail when implementers do too little to
actively spread that knowledge (KI 3,10).
“We know that knowledge [alone] does not produce
change. We need more than knowledge.” (KI 10)
Poor application of diffusion techniques
The science of large scale implementation draws upon
Rogers’ work on diffusion of innovations (KI 5), includ-
ing the use of targets and incentives (KIs 5, 11). But KIs
argued that these techniques need to be applied at the
right time to the right “unit” of the health system, or else
diffusion is unlikely to occur (KIs 5, 11, 14).
“One of the major barriers is that the wrong approach
to dissemination is used at the wrong moment in time”
(KI 14)
“One area I’ve worked in is public health targets in
low income countries and high income countries. A
very frequent complaint is that these get nowhere.
They’re statements of wish rather than instruments for
achieving change. There’s a lack of sustained attention
at the national level, a lack of incentives for people at
the sharp end of change, a lack of information, a lack
of comparators to know whether you’re lagging
behind.” (KI 5)
Non-transferability and non-scalability from trial conditions
Several KIs argued that a key reason why an intervention
that was successful in a pilot may not scale up in a “real
world” setting is diminished implementation fidelity—
that is, in the real world the intervention is not delivered
as intended (KIs 4, 5, 12, 14). The KIs argued that such
fidelity can be diminished by misjudging the readiness of
an intervention to go to scale and by differences between
the conditions under which the pilot was conducted and
the scale-up context (KIs 4, 5, 12, 14).
“RCTs [randomized controlled trials] are done under
specific conditions; you’re then transferring it [the
intervention] into a different context, with a different
case mix, different demographics, different
transportation.” (KI 4)
“It’s assumed that success in one village will work
elsewhere—it’s a naiveté to exponential scaling. Some
things will scale, some things won’t.” (KI 12)
“People go to scale prematurely; the focus has been on
efficacy, not effectiveness.” (KI 14)
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research that would help implementers to better under-
stand the local context (KIs 1,7,8,13):
“Scale-up is context-specific. We need to understand
the local context better. The case study method is to
implementation science what the RCT is to clinical
evidence.” (KI 1)
Poor models of efficient scale-up approaches
KIs discussed what they see as a knowledge deficit on
successful dissemination strategies (KIs 11–13); one of
these KIs said that the result of this deficit is that we do
not have good models for “efficient” scale-up:
“Building good models for scale up? We don’t have the
information to do it.” (KI 12)
Attributes of the “adopting” community
Lack of “community readiness” or engagement
One explanation provided by the KIs for why scale up fails
is that the targeted community was not “ready”—there
was insufficient community consultation and too little
engagement of key community stakeholders (KIs 4,12,14).
“For example, if you’re changing guidelines for
hypertension, who must you consult? Not just
policymakers, also clinicians, key opinion leaders on
the ground, and the community itself.” (KI 4)
KIs discussed the importance of research on how to
better engage the community itself in scale up efforts
(KIs 7, 10, 13):
“We need to learn from users, not providers. We need
to learn from people themselves. We need qualitative
research to see how they can tell us the solutions, so
we can work with them.” (KI 10)
“What kind of community mobilization works or not?”
(KI 13)
Scaling up, argued two KIs, requires overcoming de-
mand-side barriers (KIs 7, 12). An important avenue of
research, they explained, is to understand why commu-
nities in LMICs sometimes do not take up services when
these are provided and how these “demand side” barriers
can be overcome (KIs 7, 12).
“In scale-up, we often think of the supply side, but
there’s less emphasis on the demand side. Coke [Coca-
Cola] doesn’t scale up unless people demand it. To
increase births in facilities, women must demand it.”
(KI 12)Socio-political, fiscal, and cultural context
Financial constraints
Financial constraints at the community, national, and
global levels are constraining scale-up of a variety of
interventions (KIs 6–8, 12):
“It is very limiting if there are no funds committed
centrally by the government to scale-up.” (KI 8)
“There’s a funding gap to scale up services: 10–20
billion dollars that we don’t have.” (KI 12)
Given these financial constraints, an avenue of re-
search identified by the KIs in this study is on how to
reach the poorest and most vulnerable communities
with tools and services (KIs 3–4):
“One of the issues around scaling up is the economic
differences between groups where scale-up is
happening. Reaching the very poor is not the same as
scale-up for higher socioeconomic status. They may all
need a vaccine, but scale-up differs for these two
groups.” (KI 4)
The key informants acknowledged that mobilizing new
resources for scaling up will be important, but also that
research is needed on improving the way in which
finances are tracked:
“This could involve individual citizens or patients—
if you have a good, empowered citizenry, they can
hold institutions to account, through a consumer
process or a democratic process. I’m more
persuaded by accountability via the ballet box or
markets.” (KI 5)Lack of donor coordination
Although the last decade has seen a rise in inter-
national development assistance for health, poor coord-
ination between donors can impede implementation
(KIs 6, 12). One KI cited the work of David Fidler on
the “anarchy” occurring within the governance of global
health assistance, which he said has an impact upon
LMICs:
“The other [barrier to scale-up] is the cacophony and
anarchy that David Fidler describes—a lack of donor
coordination. It’s very hard for countries to deal with.
The World Bank comes in and expects everyone to
jump. USAID [the United States Agency for
International Development] comes in and expects
everyone to jump, and to do so with democratic
fervor.” (KI 6)
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making based on politics rather than science
KIs said that a lack of political interest in scale up
was a major barrier (KIs 12, 14); they mentioned that
campaigns to massively scale-up ART in low income
countries (such as the WHO’s “3 by 5” campaign, or
the US President’s Emergency Plan for AIDS Relief )
had helped to generate political interest in large-scale
implementation.
“Until recently, we didn’t have the political interest to
scale up.” (KI 12)
One KI noted that a barrier to implementing evi-
dence-based interventions in LMICs is that decisions get
made based on politics, rather than a proper under-
standing of the data on effectiveness and costs (KI 4). A
second KI discussed the politicization of the leadership
within ministries of health in LMICs (KI 7).
“Evidence isn’t used. People make decisions based on
politics, for example introducing the pneumococcal
vaccine with no understanding about its effectiveness
or cost-effectiveness.” (KI 4)
“It [leadership] is frequently politically aligned and not
related to health expertise.” (KI 7)
Regulatory hurdles
One KI noted that a proven strategy for going to scale
with antiretroviral drugs (ARVs) is to allow non-physicians
to prescribe them, but in some settings this is forbidden:
“There are regulatory hurdles for health systems
strengthening, such as the way medicines are
prescribed or who can prescribe medicines. For
example, if the only people who can prescribe ARVs
are doctors, that’s a big barrier in the system.”(KI 4)
Research context
Low profile of implementation science
KIs argued that the low status of implementation sci-
ence among researchers is a barrier to finding effective
ways to deliver interventions to scale, and that raising
the status of this science is a key imperative for im-
proving large-scale implementation in LMICs (KIs 2,
7–10, 14).
“Many researchers don’t see this kind of research as
exciting—don’t see it as highly academic or
challenging” (KI 8)
“There’s no well established field of inquiry—nothing
to attract young researchers into the field.” (KI 14)Limited research capacity in LMICs
Two KIs felt that researchers and institutions in LMICs
are the ones who are closest to the problems on the
ground, yet they are highly constrained in tackling these
issues by their limited research capacity (KIs 2, 12):
“Everybody has the experience of the typical
management environment, day to day, in a developing
country—it’s hand to mouth, fire fighting, ad hoc
decision making. The ability to say ‘let’s pause here
and do an operational research study’ seldom
happens. There’s no time, no training, no people to do
the work.” (KI 2)
Lack of robust research methods and innovative
research designs
Implementation science is hindered by reliance on uncon-
trolled retrospective assessments and descriptive studies
and a lack of large-scale cluster randomized studies (KIs
4, 12, 13, 14). In addition to using randomization, there is
also a need for new study designs (KI 4, 11,12,14), better
ways to capture public health data (KI 12), and new ways
to synthesize existing evidence (KI 14).
“The RCT is one way of doing evaluation. It isn’t a
bad thing. But maybe there’s an intermediate method
needed between an RCT and scale-up.” (KI 4)
“Scale-up won’t be successful until we can measure it
better.” (KI 12)
“Generally there’s a reliance on methods of evaluation
or research that don’t help us learn continually as we
expand [an intervention].” (KI 14)
Discussion
The purpose of this study was to explore, from expert inter-
views with academic leaders in the field of implementation
science, some of the key barriers to the scale-up of
proven interventions in LMICs. The study also aimed to
define a set of key research questions that need to be
addressed in order to help overcome these barriers. The
personal views expressed by KIs in this qualitative study
are valuable in that they are reflective of their “real
world” experience in implementing or researching scale-
up processes in the developing world. There are six find-
ings from this study that could have important public
health implications.
First, the KIs’ experience suggests that scale-up is less
likely if the intervention is highly complex and there is
lack of consensus about its value, a finding that is sup-
ported by the published implementation science litera-
ture [19-22]. For example, a review of scaling up by the
World Bank argued that the process of scaling up should
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and procedures for use by many people on a larger
scale” [21]. Given that KIs in this study saw complexity
as a barrier to scale-up, an important avenue for future
research that emerged from the KI interviews was ways
to reduce intervention complexity. An example of such
research is the landmark DART trial [23], which should
facilitate simplified and decentralized delivery of ART
in LMICs.
However, there are several global health interventions
that are inherently complex to implement, such as the
social marketing of condoms and the DOTS (directly
observed therapy, short course) strategy for tuberculosis
control in very low income countries [24]. It is unlikely
that these kinds of complex public health interventions
could be dramatically simplified. Gericke et al. have pro-
posed a conceptual framework for characterizing such
complexity, which has four dimensions: characteristics
of the intervention; characteristics of delivery; require-
ments on government capacity; and usage characteristics
[24]. Mangham and Hanson argue that “understanding
intervention complexity,” for example by using Gericke
et al’s framework, can help to overcome barriers to scal-
ing up complex interventions, including the important
barrier of resource constraints [15].
Second, the study findings suggest that both “leaders
and systems” influence scale-up. KIs argued that local and
national leaders play a crucial role in ensuring good gov-
ernance, developing concerted scale-up policies, and get-
ting buy-in for these policies from health workers.
Indeed empirical research has shown that strengthening
national leadership can increase the likelihood of scale-up
success [6,25,26]. For example, in 2002, Egypt’s Ministry of
Health and Population, with donor assistance, introduced
a Leadership Development Programme in Aswan Gover-
norate, which aimed “to improve health services in three
districts by increasing managers' ability to create high per-
forming teams and lead them to achieve results” [26]. The
program was associated with an increase in the number of
new family planning visits and a fall in the maternal mor-
tality rate compared with control districts. Yet despite the
emerging evidence of the importance of strong leadership,
there has been little research on identifying and fostering
“implementation leaders.”
While leaders play a role in championing a global
health intervention, its delivery to scale also needs strong
“systems components,” especially a robust healthcare
workforce. Many LMICs are currently grappling with a
crisis in human resources for health (HRH), caused by
factors such as under-investment in health education; the
HIV/AIDS epidemic, which has increased the workload
on health professionals and exposed them to infection;
and brain drain of health professionals [27,28]. The crisis
is impeding scale-up of many global health interventionsthat are critical to reaching the health-related MDGs, in-
cluding interventions related to HIV, sexual health, ma-
ternal health, and mental health [29-39]. The Joint
Learning Initiative, a consortium of over 100 global
health leaders with expertise in HRH, has stated that "the
only route to reaching the health MDGs is through the
[health] worker; there are no short cuts" [28].
The specific nature of the HRH crisis varies between
countries, for example in the geographic distribution of
health workers, the nature of the staff shortages at differ-
ent levels of the health service, and the proportion of
workers who have received high quality training [28,40].
There is therefore no single, simple “blueprint” for solv-
ing this crisis—long-term solutions will depend to some
extent upon the local context.
The KIs argued that an important research question
that could help to address the HRH crisis is how best to
train and incentivize a cadre of workers, including com-
munity health workers, to deliver the tools needed to
reach the health MDGs. Health worker incentives have
become an important focus of attention in discussions
on the HRH crisis in sub-Saharan Africa [41-43].
Mathauer and Imhoff, for example, argue that “experi-
ence and the evidence suggest that any comprehensive
strategy to maximize health worker motivation in a
developing country context has to involve a mix of fi-
nancial and non-financial incentives” [41]. Their recent
qualitative study of health worker motivation in Kenya
and Benin suggested that these non-financial incentives
include ensuring that workers have the equipment, sup-
plies, and training that they need to do their job to a
high professional standard [41].
Given that the HRH crisis is felt particularly acutely
in the public sector, KIs argued that implementation
research should also include how best to engage non-
state actors, including NGOs and the private sector, in
scale-up efforts. Leveraging the non-state health sector,
including improving the quality of services provided by
private health providers such as through social franchis-
ing initiatives, is seen by many commentators as an im-
portant mechanism for overcoming barriers to achieving
the MDGs [39].
The global campaign to scale up effective malaria
drugs—artemisinin-based combination therapies (ACTs)—
is a good case in point. Weak public sector health systems,
including health worker shortages and weak drug supply
chains causing drug stock-outs, have hindered efforts to
ensure that all patients with uncomplicated falciparum
malaria receive ACTs [44,45]. Makundi and colleagues
argue that in Tanzania, “limited human resources for
malaria interventions, especially at the district level,
impact negatively on the delivery of interventions” [45].
There is growing realization within the global health
community that non-state actors, including pharmacies
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an important role in scaling up ACTs [46,47]. Two re-
cent sub-national trials, one randomized and the other
quasi-randomized, showed that introducing an ACT
price subsidy into the private sector supply chain can sig-
nificantly reduce ACT prices in retail stores and increase
their use [48,49]. Based on the success of such small
pilots, a price subsidy scheme, called the Affordable
Medicines Facility-malaria, is currently being piloted at
national level in eight LMICs [50].
Third, “engagement matters.” Based on their experi-
ences of successful scale-up, KIs emphasized that global
health initiatives are likely to fail unless they engage
local implementers and the recipient community itself,
an assertion supported by a growing body of research
evidence [7,20]. Studies are needed to better understand
what makes a community “ready” or “activated” for scale-
up, why communities sometimes fail to take up proven
interventions, and how such “demand side” barriers can
be overcome. Reaching and engaging the poorest com-
munities remains a stubborn problem and an ongoing
research imperative [7,13].
Fourth, although there is a large literature on diffusion
techniques, including on the diffusion of innovations
and the application of social network theories to scale-
up, [6,51] nevertheless KIs pointed out that there remain
large gaps in our understanding of which techniques
work best at which time and which level of the health
system. The global health community still lacks good
models for efficient scale-up approaches.
Fifth, an important finding emerging from this study is
that scaling up an intervention is not an isolated process.
Its failure or success is closely tied with a complex array
of contextual factors, such as political will, politics, the
regulatory environment, the donor environment (includ-
ing whether donors coordinate their efforts or act in iso-
lation) [52], and the fiscal environment. These can
operate at multiple levels of the health system. For
example, the research literature suggests that financial
constraints to scale-up act at the individual, household,
community, national, and international levels [53].
Finally, KIs argued that implementation research plays
a valuable role in the process of translating proven inter-
ventions into public health gains, and yet such research
currently suffers from its low status and priority and its
lack of funding. An expert meeting held in 2010 at the
Fogarty International Center at the U.S. National Insti-
tutes of Health, on “implementation science and global
health,” concluded that this type of research could act as
“the engine of accelerated progress” [54]. Whitworth and
colleagues propose that “strong health research systems
and research programmes that address bottlenecks to
upscaling effective interventions should be developed
without delay” [10].Study limitations
To the best of my knowledge, this is the first qualitative
study of global health professionals, who are also aca-
demic leaders in the field of implementation science,
to have explored their views on barriers to large-scale
implementation in global health. The KIs’ views on oper-
ational successes and failures gave a “pragmatic, real
world” dimension to the study results.
Nevertheless, the study has at least three major limita-
tions. First, this was a small qualitative study, with only
14 KIs. Including a larger number of KIs may have led
to identification of additional, important themes.
Second, most of the KIs have been affiliated with inter-
national health agencies, donor agencies, or research
institutions that are headquartered in high-income coun-
tries, while only five (KIs 4,8,10,12,14) have been directly
involved in delivering or studying implementation at
the local level. The demographic make-up of the KIs
(i.e., their professional background and institutional
affiliation) is likely to have influenced their views on the
difficulties of scaling up global health interventions. The
results of the study may have been different if it had
included a broader range of experts in scaling up,
including more who are directly involved in local “on
the ground” implementation.
Donors and international agencies, for example, who
were well represented in this study, tend to have a differ-
ent approach towards solving global health challenges
than local implementers. In malaria control, they tend to
favor a “visible quick-fix solution” [55] over more com-
plex approaches. The specific demographic make-up of
the KIs may also have played a role in their views on
community engagement. Donor agencies have been criti-
cized for viewing community engagement in a “top-
down” manner, as a way to increase the chances of
donor-led interventions—especially disease-specific, ver-
tical programs—being scaled up [56]. In contrast, local
implementers may have a more “bottom up” view, in
which local ownership of the intervention is paramount
[56]. While donors have publicly agreed to support coun-
try ownership of how development assistance is used, as
reflected in the Paris Declaration on Aid Effectiveness,
[57] a recent study found that donors were doing poorly
at living up to the declaration’s principles and are still
largely dictating the terms of how such aid is used [58].
Third, the study had only one author. This limita-
tion could have introduced bias into the coding of
the transcripts.Conclusions
Despite these caveats, the study may be of value to pol-
icymakers and researchers tackling implementation pro-
blems, because it suggests an initial series of “next steps”
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http://www.globalizationandhealth.com/content/8/1/11in translating knowledge into large-scale change in glo-
bal health. These include studying ways to: simplify
interventions; train future “scale-up leaders”; build and
incentivize an implementation workforce; reach and
engage recipient communities, especially the poorest;
apply the most effective diffusion techniques for scaling
up the right tools at the right time in the right place
within a health system; and raise the low profile of im-
plementation science. An accompanying article—a short
essay—which was also based on these key informant
interviews, has laid out some of the “success factors”
associated with successful scale-up [59]. The next steps
laid out above will be challenging to achieve, but the
stakes are high. Without concerted action, argue Sanders
and Haines, “the unconscionable gap between know-
ledge and its implementation will persist in the health
field [60].”Additional file
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